2.41
price down icon2.03%   -0.05
after-market Dopo l'orario di chiusura: 2.35 -0.06 -2.49%
loading
Precedente Chiudi:
$2.46
Aprire:
$2.48
Volume 24 ore:
98,838
Relative Volume:
0.54
Capitalizzazione di mercato:
$7.29M
Reddito:
-
Utile/perdita netta:
$-31.88M
Rapporto P/E:
-3.2133
EPS:
-0.75
Flusso di cassa netto:
$-25.20M
1 W Prestazione:
+9.55%
1M Prestazione:
+7.59%
6M Prestazione:
-70.79%
1 anno Prestazione:
-90.50%
Intervallo 1D:
Value
$2.345
$2.4855
Intervallo di 1 settimana:
Value
$2.13
$2.49
Portata 52W:
Value
$2.05
$26.76

In 8 Bio Inc Stock (INAB) Company Profile

Name
Nome
In 8 Bio Inc
Name
Telefono
(646) 600-6438
Name
Indirizzo
EMPIRE STATE BUILDING, NEW YORK
Name
Dipendente
18
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
INAB's Discussions on Twitter

Confronta INAB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INAB
In 8 Bio Inc
2.41 8.47M 0 -31.88M -25.20M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-03-18 Iniziato Laidlaw Buy
2022-08-30 Iniziato H.C. Wainwright Buy

In 8 Bio Inc Borsa (INAB) Ultime notizie

pulisher
Jul 24, 2025

Will Passage Bio Inc. stock benefit from interest rate changesAccelerated earnings growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace

Jul 24, 2025
pulisher
Jul 24, 2025

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference - Stock Titan

Jul 24, 2025
pulisher
Jul 22, 2025

Tourmaline Bio Inc. Stock Analysis and ForecastHigh-yield market plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about 2seventy bio Inc. stockExceptional return forecasts - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - The Globe and Mail

Jul 20, 2025
pulisher
Jul 19, 2025

What drives Mustang Bio Inc. stock priceMarket-leading growth rates - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about TELA Bio Inc. stockBreakout stock performance - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Upstream Bio, Inc. shares fall 4.98% premarket after HBM Healthcare Investments reports an 8.4% decline in NAV per share. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Boundless Bio Inc. stock pricePowerful profit generation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Gossamer Bio Inc. Stock Analysis and ForecastMarket-leading capital gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Why Climb Bio Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Kronos Bio Inc. stock attracts strong analyst attentionFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 11, 2025
pulisher
Jul 09, 2025

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Pre-market Movers: CLDI, BMGL, PROK, RXST... - RTTNews

Jul 09, 2025
pulisher
Jul 09, 2025

KALA BIO Announces Completion of Enrollment in CHASE - GlobeNewswire

Jul 09, 2025
pulisher
Jul 08, 2025

Cizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood Test for Lung Cancer - Yahoo Finance

Jul 08, 2025
pulisher
Jul 07, 2025

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - Yahoo Finance

Jul 07, 2025
pulisher
Jul 07, 2025

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to - GlobeNewswire

Jul 07, 2025
pulisher
Jun 30, 2025

Clinical-Stage Biotech INmune Bio Secures $19M Through Strategic Share Offering - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Breakthrough: New Alzheimer's Drug XPro Shows Promise in Key Patient Group, Zero ARIA Cases - Stock Titan

Jun 30, 2025
pulisher
Jun 28, 2025

NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 27, 2025

Clinical-Stage Immunology Company INmune Bio Secures $19M from Healthcare Investors at Market Price - Stock Titan

Jun 27, 2025
pulisher
Jun 26, 2025

Major Alzheimer's Treatment Milestone: INmune Bio Reveals Phase 2 Trial Results Next Week - Stock Titan

Jun 26, 2025
pulisher
Jun 25, 2025

BioCryst's ORLADEYO Pediatric HAE Review Extended by FDA to December 2025 | BCRX SEC FilingForm 8-K - Stock Titan

Jun 25, 2025
pulisher
Jun 23, 2025

Breakthrough in Dementia Treatment: Gene Therapy Maintains 18-Month Efficacy with Lower Dose Success - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

ANVS gains NYSE approval of compliance plan, delisting risk eased | ANVS SEC FilingForm 8-K - Stock Titan

Jun 20, 2025
pulisher
Jun 19, 2025

Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight - GlobeNewswire

Jun 19, 2025
pulisher
Jun 18, 2025

Nuvation Bio: A Justified Fall Based On Post-Marketing Requirements (NYSE:NUVB) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 11, 2025

U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer - Quantisnow

Jun 11, 2025
pulisher
Jun 11, 2025

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Breakthrough: New Drug Reduces Alzheimer's Risk After Brain Injury, DoD-Backed Study Shows - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial - GlobeNewswire Inc.

Jun 09, 2025
pulisher
Jun 03, 2025

European Launch: TELA Bio's Natural Hernia Repair Device Shows 98.8% Success Rate - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

TELA Bio Appoints Jeffrey Blizard as President - GlobeNewswire

Jun 02, 2025
pulisher
May 29, 2025

Pre-market Movers: ALZN, HCTI, REVB, NTLA... - RTTNews

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025
pulisher
May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025
pulisher
May 22, 2025

GRI Bio Presents Positive Pre-Clinical Data Demonstrating - GlobeNewswire

May 22, 2025
pulisher
May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025
pulisher
May 19, 2025

Protagenic Therapeutics Completes Acquisition of Phytanix Bio - TipRanks

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025
pulisher
May 16, 2025

GRI Bio CEO Reveals Latest Developments in Revolutionary NKT Cell Technology at Major Healthcare Conference - Stock Titan

May 16, 2025
pulisher
May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025

In 8 Bio Inc Azioni (INAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):